Evidence map›Paper›PMID 37107672›Full record

ArticleGenes2023

The Influence of

Bogna Grygiel-Górniak, Iwona Ziółkowska-Suchanek, Lidia Szymkowiak, Natalia Rozwadowska, Elżbieta Kaczmarek

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 92% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Bogna Grygiel-GórniakDepartment of Rheumatology, Rehabilitation and Internal Diseases, Poznan University of Medical Sciences, 61-701 Poznan, Poland.ORCID 0000-0002-3438-0764
Iwona Ziółkowska-SuchanekInstitute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.ORCID 0000-0001-8813-5003
Lidia SzymkowiakInstitute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.
Natalia RozwadowskaInstitute of Human Genetics, Polish Academy of Sciences, 60-479 Poznan, Poland.ORCID 0000-0002-5111-0870
Elżbieta KaczmarekDepartment of Bioinformatics and Computational Biology, Poznan University of Medical Sciences, 60-806 Poznan, Poland.
Institute of Human Genetics · PLPoznan University of Medical Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recently, we have observed two significant pandemics caused by communicable (COVID-19) and non-communicable factors (obesity). Obesity is related to a specific genetic background and characterized by immunogenetic features, such as low-grade systemic inflammation. The specific genetic variants include the presence of polymorphism of the Peroxisome Proliferator-Activated Receptors gene (

Indexed as

COVID-19PPAR gammaFemaleGenetic Predisposition to DiseaseGTPase-Activating ProteinsHumansObesityPolymorphism, GeneticPostmenopauseFAM13A protein, humanGTPase-Activating ProteinsPPAR gamma3β-ARFAM13AhypertensionimmunogeneticsobesitypolymorphismsPPAR-γ2

Identifiers

PMID37107672
PMCPMC10137345
OpenAlexW4365509246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.